| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 14:37 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Older filings | ||||||
| Filed 2025-12-22 12:45 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$207,120
+24,000 vol $8.63 each |
||
| Filed 2025-12-19 20:55 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$207,120
+24,000 vol $8.63 each |
||
| Filed 2026-01-24 11:53 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$56,000
+5,000 vol $11.20 each |
48,500 | |
| Filed 2026-01-24 11:52 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-56,000
-5,000 vol $11.20 each |
0 | |
| Filed 2025-12-22 12:45 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$207,120
+24,000 vol $8.63 each |
24,000 | |
| Filed 2025-12-19 20:55 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$207,120
+24,000 vol $8.63 each |
||
| Filed 2025-12-19 20:56 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$690,400
+80,000 vol $8.63 each |
340,000 | |
| Filed 2025-12-19 20:55 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$207,120
+24,000 vol $8.63 each |
24,000 | |
| Filed 2025-12-19 20:55 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-26 13:16 Tx date 2025-11-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$61,660
+7,000 vol $8.81 each |
43,500 | |
| Filed 2025-11-26 13:10 Tx date 2025-11-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,700
+3,000 vol $8.90 each |
36,500 | |
| Filed 2025-11-26 13:09 Tx date 2025-11-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,275
+1,500 vol $8.85 each |
33,500 | |
| Filed 2025-11-26 13:09 Tx date 2025-11-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,240
+4,800 vol $8.80 each |
32,000 | |
| Filed 2025-03-27 14:17 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$359,800
+70,000 vol $5.14 each |
260,000 | |
| Filed 2024-05-22 23:41 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,200
+70,000 vol $3.96 each |
190,000 | |
| Filed 2023-08-20 12:02 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$35,000
+5,000 vol $7.00 each |
27,200 | |
| Filed 2023-03-31 14:10 Tx date 2023-03-30 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,725
+900 vol $4.14 each |
22,200 | |
| Filed 2023-03-31 14:09 Tx date 2023-03-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,310
+9,100 vol $4.10 each |
21,300 | |
| Filed 2022-12-12 20:26 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$462,000
+120,000 vol $3.85 each |
120,000 | |